Table of Contents
ISRN Nephrology
Volume 2013, Article ID 395467, 5 pages
http://dx.doi.org/10.5402/2013/395467
Research Article

Evaluation of an Isolation Program of Hepatitis C Virus Infected Hemodialysis Patients in Some Hemodialysis Centers in Egypt

1Department of Medicine, Cairo Hospital, 41 Manial Street, Cairo 11451, Egypt
2Department of Public Health, Cairo Hospital, 41 Manial Street, Cairo 11451, Egypt

Received 3 August 2012; Accepted 15 September 2012

Academic Editors: J. Almirall and H. C. Rayner

Copyright © 2013 Amin R. Soliman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Williams, “Epidemiology of hepatitis C in the United States,” American Journal of Medicine, vol. 107, no. 6, pp. 2–9, 1999. View at Google Scholar · View at Scopus
  2. M. A. Darwish, T. A. Raouf, P. Rushdy, N. T. Constantine, M. R. Rao, and R. Edelman, “Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors,” American Journal of Tropical Medicine and Hygiene, vol. 49, no. 4, pp. 440–447, 1993. View at Google Scholar · View at Scopus
  3. B. J. G. Pereira and A. S. Levey, “Hepatitis C virus infection in dialysis and renal transplantation,” Kidney International, vol. 51, no. 4, pp. 981–999, 1997. View at Google Scholar · View at Scopus
  4. A. Hassan and R. Khalil, “Prevalence of anti-HCV seropositivity among haemodialysis patients in Cairo,” in Proceedings of the 10th Annual Congress of the Egyptian Society of Nephrology, Cairo, 1999.
  5. C. Medin, T. Allander, M. Roll, S. H. Jacobson, and L. Grillner, “Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study,” Nephron, vol. 65, no. 1, pp. 40–45, 1993. View at Google Scholar · View at Scopus
  6. M. Favero, J. Tokars, and M. Alter, Nosocomial Infection Associated with Hemodialysis. Hospital Epidemiology and Infection Control, Lippincott, Williams and Wilkins, Philadelphia, Pa, USA, 2nd edition, 1999.
  7. M. Chiaramonte, T. Stroffolini, U. Lorenzoni et al., “Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy,” Journal of Hepatology, vol. 24, no. 2, pp. 129–134, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Marchesi, I. Aric, and E. Poletti, “Outbreak of HCV infection in hemodialysis patients,” Nephrology Dialysis Transplantation, vol. 13, pp. 795–799, 1998. View at Google Scholar
  9. M. A. Carneiro, S. A. Teles, M. A. Dias et al., “Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of sur­veillance,” Memórias do Instituto Oswaldo Cruz, vol. 100, no. 4, pp. 345–349, 2005. View at Google Scholar
  10. J. Bukh, P. Wantzin, K. Krogsgaard, F. Knudsen, R. H. Purcell, and R. H. Miller, “High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection,” Journal of Infectious Diseases, vol. 168, no. 6, pp. 1343–1348, 1993. View at Google Scholar · View at Scopus
  11. T. G. . Wreghitt, “Blood-borne virus infections in dialysis units,” Reviews in Medical Virology, vol. 9, pp. 101–109, 1999. View at Google Scholar
  12. A. Hassan and R. Khalil, “Hepatitis C in dialysis patients in Egypt: relationship to dialysis duration, blood transfusion, and liver disease,” Saudi Journal of Kidney Diseases and Transplantation, vol. 11, pp. 72–73, 2000. View at Google Scholar
  13. Y. Iwasaki, M. Esumi, N. Hosokawa, M. Yanai, and K. Kawano, “Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection,” Journal of Hospital Infection, vol. 45, no. 1, pp. 54–61, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. P. M. Schneeberger, I. Keur, A. M. Van Loon et al., “The prevalence and incidence of hepatitis C virus infections among dialysis patients in The Netherlands: a nationwide prospective study,” Journal of Infectious Diseases, vol. 182, no. 5, pp. 1291–1299, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Gallego, A. Lopez, J. Perez et al., “Effect of isolation measures on the incidence and pre­valence of hepatitis C virus infection in hemo­dialysis,” Nephron Clinical Practice, vol. 104, pp. c1–c6, 2006. View at Google Scholar
  16. C. S. Yang, H. H. Chang, C. C. Chou, and S. J. Peng, “­lation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit,” Journal of the Formosan Medical Association, vol. 102, pp. 79–85, 2003. View at Google Scholar
  17. P. Gilli, S. Soffritti, E. De Paoli Vitali, and P. L. Bedani, “Prevention of hepatitis C virus in dialysis units,” Nephron, vol. 70, no. 3, pp. 301–306, 1995. View at Google Scholar · View at Scopus
  18. F. A. Shaheen, S. O. Huraib, R. Al-Rashed et al., “Prevalence of hepatitis C antibodies among he­modialysis patients in Jeddah area, Saudi Arabia,” Saudi Medical Journals, vol. 2, pp. S125–S126, 2003. View at Google Scholar
  19. M. A. S. Carneiro, R. M. B. Martins, S. A. Teles et al., “Hepatitis C prevalence and risk factors in he¬modialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods,” Memorias do Instituto Oswaldo Cruz, vol. 96, no. 6, pp. 765–769, 2001. View at Google Scholar · View at Scopus
  20. S. F. O'Brien, Q. L. Yi, W. Fan, V. Scalia, S. H. Kleinman, and E. C. Vamvakas, “Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services,” Transfusion, vol. 47, no. 2, pp. 316–325, 2007. View at Publisher · View at Google Scholar · View at Scopus